Correlation Between L Abbett and Tekla Healthcare
Can any of the company-specific risk be diversified away by investing in both L Abbett and Tekla Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining L Abbett and Tekla Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between L Abbett Growth and Tekla Healthcare Opportunities, you can compare the effects of market volatilities on L Abbett and Tekla Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in L Abbett with a short position of Tekla Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of L Abbett and Tekla Healthcare.
Diversification Opportunities for L Abbett and Tekla Healthcare
-0.74 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between LGLUX and Tekla is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding L Abbett Growth and Tekla Healthcare Opportunities in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tekla Healthcare Opp and L Abbett is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on L Abbett Growth are associated (or correlated) with Tekla Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tekla Healthcare Opp has no effect on the direction of L Abbett i.e., L Abbett and Tekla Healthcare go up and down completely randomly.
Pair Corralation between L Abbett and Tekla Healthcare
Assuming the 90 days horizon L Abbett Growth is expected to generate 1.12 times more return on investment than Tekla Healthcare. However, L Abbett is 1.12 times more volatile than Tekla Healthcare Opportunities. It trades about 0.17 of its potential returns per unit of risk. Tekla Healthcare Opportunities is currently generating about -0.18 per unit of risk. If you would invest 4,348 in L Abbett Growth on September 23, 2024 and sell it today you would earn a total of 641.00 from holding L Abbett Growth or generate 14.74% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
L Abbett Growth vs. Tekla Healthcare Opportunities
Performance |
Timeline |
L Abbett Growth |
Tekla Healthcare Opp |
L Abbett and Tekla Healthcare Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with L Abbett and Tekla Healthcare
The main advantage of trading using opposite L Abbett and Tekla Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if L Abbett position performs unexpectedly, Tekla Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tekla Healthcare will offset losses from the drop in Tekla Healthcare's long position.L Abbett vs. Lord Abbett Trust | L Abbett vs. Lord Abbett Trust | L Abbett vs. Lord Abbett Focused | L Abbett vs. Floating Rate Fund |
Tekla Healthcare vs. Tekla Healthcare Investors | Tekla Healthcare vs. Tekla Life Sciences | Tekla Healthcare vs. Cohen Steers Reit | Tekla Healthcare vs. XAI Octagon Floating |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |